Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Male Infertility Market, by Treatment
1.4.2 North America Male Infertility Market, by Tests
1.4.3 North America Male Infertility Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Male Infertility Market by Treatment
3.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 North America Medication Market by Country
Chapter 4. North America Male Infertility Market by Test
4.1 North America DNA Fragmentation Technique Market by Country
4.2 North America Oxidative Stress Analysis Market by Country
4.3 North America Computer Assisted Semen Analysis Market by Country
4.4 North America Microscopic Examination Market by Country
4.5 North America Sperm Agglutination Market by Country
4.6 North America Sperm Penetration Assay Market by Country
4.7 North America Other Test Market by Country
Chapter 5. North America Male Infertility Market by Country
5.1 US Male Infertility Market
5.1.1 US Male Infertility Market by Treatment
5.1.2 US Male Infertility Market by Test
5.2 Canada Male Infertility Market
5.2.1 Canada Male Infertility Market by Treatment
5.2.2 Canada Male Infertility Market by Test
5.3 Mexico Male Infertility Market
5.3.1 Mexico Male Infertility Market by Treatment
5.3.2 Mexico Male Infertility Market by Test
5.4 Rest of North America Male Infertility Market
5.4.1 Rest of North America Male Infertility Market by Treatment
5.4.2 Rest of North America Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
Unique Offerings 
